0

Close
 
Upcoming Allied Market Research
2023
Medication Management Market

Medication Management Market: Global Opportunity Analysis and Industry Forecast, 2023-2030 Market

LS : Healthcare
Report Code: A10470
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Medication Management Market

Request Now !

Medication Management Market Outlook - 2027

Medication management is a service provided typically by pharmacists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them. This includes providing education on the disease state and medications used to treat the disease state, ensuring that medicines are taken correctly, reducing waste due to unused medicines, looking for any side effects, and providing education on how to manage any side effects. The process that can be broken down into five steps: medication therapy review, personal medication record, medication-related action plan, intervention and or referral, and documentation and follow-up. The medication therapy review has the pharmacist review all of the prescribed medications, any over-the-counter medications, and all dietary supplements an individual is taking. This allows the pharmacist to look for any duplications or dangerous drug interactions. This service can be especially valuable for people who are older, have several chronic conditions, take multiple medications, or are seen by multiple doctors.

Medication-Management

COVID-19 scenario analysis:

Coronavirus disease 2019 (COVID-19) has created an economic crisis along with a healthcare crisis. COVID-19 pandemic has stretched healthcare system worldwide, wherein developed countries are expected to cause economic recession. The COVID-19 pandemic has an adverse impact on the healthcare system, resulting in 50% to 70% drop in revenue from March 2020. Many small hospitals, clinics, and nursing homes, have been forced to shut their operations. Social distancing and localized curfews have resulted in delayed elective surgical procedures. In addition, visa cancellations have led to a hiatus in medical tourism and can negatively impact the healthcare services market growth.

Top impacting factors: Market scenario analysis, trends, drivers, and impact analysis

The major factor affecting the industry includes increase in the number of technological innovations at a positive pace. The key provision for medication management services under healthcare reforms is anticipated to propel the industry in the next few years. The surge in the growth in aging population and increased number of incidences of chronic illness are expected to fuel the demand for medication management systems over the forecast period. Furthermore, it helps to reduce the healthcare costs, which is the need of the hour; hence, it would help the industry flourish in the coming years. However, higher maintenance cost may hinder the market growth.

Increase in the number of aging population to boost the medication management market

According to the statistics given by the United Nations, in 2017, the global population aged 60 years or over was 962 million in 2017, more than twice as high as in 1980, when there were 382 million older persons worldwide. The number of older persons is expected to double again by 2050, when it is projected to reach nearly 2.1 billion.

In 2030, older persons are expected to outnumber children under age 10 (1.41 billion versus 1.35 billion); in 2050, projections indicate that there will be older persons aged 60 or over than adolescents and youth at ages 10-24 (2.1 billion versus 2.0 billion). The growth in the population of individuals aged 60 years and above has propelled the demand for the medication management industry.

Surge in number of chronic diseases to propel the market

According to the data published by the World Health Organization - the World Health Report 2002, reducing risks and promoting healthy life indicate that the mortality, morbidity, and disability attributed to the major chronic diseases currently account for almost 60% of all deaths and 43% of the global burden of disease. By 2020, their contribution is expected to rise to 73% of all deaths and 60% of the global burden of disease.

Moreover, 79% of the deaths attributed to these diseases occur in developing countries. Four of the most prominent chronic diseases – cardiovascular diseases (CVD), cancer, chronic obstructive pulmonary disease, and type 2 diabetes – are linked by common and preventable biological risk factors, notably high blood pressure, high blood cholesterol, overweight, and by related major behavioral risk factors such as unhealthy diet, physical inactivity, and tobacco use. Action to prevent these major chronic diseases should focus on controlling these and other key risk factors in a well-integrated manner.

Key benefits of the report:

  • This study presents the analytical depiction of the global medication management market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global medication management market share.
  • The current market is quantitatively analyzed to highlight the global medication management market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global medication management market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the market research report:

  • Which are the leading market players active in the market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What are the projections for the future that would help in taking further strategic steps?

 Medication Management Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 Report Highlights

Aspects Details
By System
  • Clinical Decision Support Systems
  • Computerized Physician Order Entry Systems
  • Assurance Systems
  • Inventory Management Systems
  • Administration Software
  • Automated Dispensing Systems
By Service
  • Adverse Drug Effects Surveillance
  • Medication Analytics
  • Point-of-Care Verification
By Mode of Delivery
  • Web-based
  • Cloud-based
  • On-premise
By End User
  • Pharmacies
  • Hospitals
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Carefusion Corporation,, Omnicell, Inc., Meditech, Cerner Corporation,, Siemens Healthcare (Subsidiary Of Siemens Ag),, Quadramed Corporation,, Optum Inc.,, Mckesson Corporation,, GE Healthcare (A Division Of General Electric Company),, Allscripts Healthcare Solutions, Inc.,
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: MEDICATION MANAGEMENT MARKET, BY SYSTEM

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By System

    • 4.2. Clinical Decision Support Systems

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Computerized Physician Order Entry Systems

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Assurance Systems

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Inventory Management Systems

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Administration Software

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Automated Dispensing Systems

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

  • CHAPTER 5: MEDICATION MANAGEMENT MARKET, BY SERVICE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Service

    • 5.2. Adverse Drug Effects Surveillance

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Medication Analytics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Point-of-Care Verification

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: MEDICATION MANAGEMENT MARKET, BY MODE OF DELIVERY

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Mode Of Delivery

    • 6.2. Web-based

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Cloud-based

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. On-premise

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: MEDICATION MANAGEMENT MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Pharmacies

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Hospitals

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Others

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

  • CHAPTER 8: MEDICATION MANAGEMENT MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By System

      • 8.2.3. Market Size and Forecast, By Service

      • 8.2.4. Market Size and Forecast, By Mode Of Delivery

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Medication Management Market

        • 8.2.7.1. Market Size and Forecast, By System
        • 8.2.7.2. Market Size and Forecast, By Service
        • 8.2.7.3. Market Size and Forecast, By Mode Of Delivery
        • 8.2.7.4. Market Size and Forecast, By End User

      • 8.2.8. Canada Medication Management Market

        • 8.2.8.1. Market Size and Forecast, By System
        • 8.2.8.2. Market Size and Forecast, By Service
        • 8.2.8.3. Market Size and Forecast, By Mode Of Delivery
        • 8.2.8.4. Market Size and Forecast, By End User

      • 8.2.9. Mexico Medication Management Market

        • 8.2.9.1. Market Size and Forecast, By System
        • 8.2.9.2. Market Size and Forecast, By Service
        • 8.2.9.3. Market Size and Forecast, By Mode Of Delivery
        • 8.2.9.4. Market Size and Forecast, By End User

    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By System

      • 8.3.3. Market Size and Forecast, By Service

      • 8.3.4. Market Size and Forecast, By Mode Of Delivery

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Medication Management Market

        • 8.3.7.1. Market Size and Forecast, By System
        • 8.3.7.2. Market Size and Forecast, By Service
        • 8.3.7.3. Market Size and Forecast, By Mode Of Delivery
        • 8.3.7.4. Market Size and Forecast, By End User

      • 8.3.8. Germany Medication Management Market

        • 8.3.8.1. Market Size and Forecast, By System
        • 8.3.8.2. Market Size and Forecast, By Service
        • 8.3.8.3. Market Size and Forecast, By Mode Of Delivery
        • 8.3.8.4. Market Size and Forecast, By End User

      • 8.3.9. Italy Medication Management Market

        • 8.3.9.1. Market Size and Forecast, By System
        • 8.3.9.2. Market Size and Forecast, By Service
        • 8.3.9.3. Market Size and Forecast, By Mode Of Delivery
        • 8.3.9.4. Market Size and Forecast, By End User

      • 8.3.10. Spain Medication Management Market

        • 8.3.10.1. Market Size and Forecast, By System
        • 8.3.10.2. Market Size and Forecast, By Service
        • 8.3.10.3. Market Size and Forecast, By Mode Of Delivery
        • 8.3.10.4. Market Size and Forecast, By End User

      • 8.3.11. UK Medication Management Market

        • 8.3.11.1. Market Size and Forecast, By System
        • 8.3.11.2. Market Size and Forecast, By Service
        • 8.3.11.3. Market Size and Forecast, By Mode Of Delivery
        • 8.3.11.4. Market Size and Forecast, By End User

      • 8.3.12. Russia Medication Management Market

        • 8.3.12.1. Market Size and Forecast, By System
        • 8.3.12.2. Market Size and Forecast, By Service
        • 8.3.12.3. Market Size and Forecast, By Mode Of Delivery
        • 8.3.12.4. Market Size and Forecast, By End User

      • 8.3.13. Rest Of Europe Medication Management Market

        • 8.3.13.1. Market Size and Forecast, By System
        • 8.3.13.2. Market Size and Forecast, By Service
        • 8.3.13.3. Market Size and Forecast, By Mode Of Delivery
        • 8.3.13.4. Market Size and Forecast, By End User

    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By System

      • 8.4.3. Market Size and Forecast, By Service

      • 8.4.4. Market Size and Forecast, By Mode Of Delivery

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Medication Management Market

        • 8.4.7.1. Market Size and Forecast, By System
        • 8.4.7.2. Market Size and Forecast, By Service
        • 8.4.7.3. Market Size and Forecast, By Mode Of Delivery
        • 8.4.7.4. Market Size and Forecast, By End User

      • 8.4.8. Japan Medication Management Market

        • 8.4.8.1. Market Size and Forecast, By System
        • 8.4.8.2. Market Size and Forecast, By Service
        • 8.4.8.3. Market Size and Forecast, By Mode Of Delivery
        • 8.4.8.4. Market Size and Forecast, By End User

      • 8.4.9. India Medication Management Market

        • 8.4.9.1. Market Size and Forecast, By System
        • 8.4.9.2. Market Size and Forecast, By Service
        • 8.4.9.3. Market Size and Forecast, By Mode Of Delivery
        • 8.4.9.4. Market Size and Forecast, By End User

      • 8.4.10. South Korea Medication Management Market

        • 8.4.10.1. Market Size and Forecast, By System
        • 8.4.10.2. Market Size and Forecast, By Service
        • 8.4.10.3. Market Size and Forecast, By Mode Of Delivery
        • 8.4.10.4. Market Size and Forecast, By End User

      • 8.4.11. Australia Medication Management Market

        • 8.4.11.1. Market Size and Forecast, By System
        • 8.4.11.2. Market Size and Forecast, By Service
        • 8.4.11.3. Market Size and Forecast, By Mode Of Delivery
        • 8.4.11.4. Market Size and Forecast, By End User

      • 8.4.12. Thailand Medication Management Market

        • 8.4.12.1. Market Size and Forecast, By System
        • 8.4.12.2. Market Size and Forecast, By Service
        • 8.4.12.3. Market Size and Forecast, By Mode Of Delivery
        • 8.4.12.4. Market Size and Forecast, By End User

      • 8.4.13. Malaysia Medication Management Market

        • 8.4.13.1. Market Size and Forecast, By System
        • 8.4.13.2. Market Size and Forecast, By Service
        • 8.4.13.3. Market Size and Forecast, By Mode Of Delivery
        • 8.4.13.4. Market Size and Forecast, By End User

      • 8.4.14. Indonesia Medication Management Market

        • 8.4.14.1. Market Size and Forecast, By System
        • 8.4.14.2. Market Size and Forecast, By Service
        • 8.4.14.3. Market Size and Forecast, By Mode Of Delivery
        • 8.4.14.4. Market Size and Forecast, By End User

      • 8.4.15. Rest of Asia Pacific Medication Management Market

        • 8.4.15.1. Market Size and Forecast, By System
        • 8.4.15.2. Market Size and Forecast, By Service
        • 8.4.15.3. Market Size and Forecast, By Mode Of Delivery
        • 8.4.15.4. Market Size and Forecast, By End User

    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By System

      • 8.5.3. Market Size and Forecast, By Service

      • 8.5.4. Market Size and Forecast, By Mode Of Delivery

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Medication Management Market

        • 8.5.7.1. Market Size and Forecast, By System
        • 8.5.7.2. Market Size and Forecast, By Service
        • 8.5.7.3. Market Size and Forecast, By Mode Of Delivery
        • 8.5.7.4. Market Size and Forecast, By End User

      • 8.5.8. South Africa Medication Management Market

        • 8.5.8.1. Market Size and Forecast, By System
        • 8.5.8.2. Market Size and Forecast, By Service
        • 8.5.8.3. Market Size and Forecast, By Mode Of Delivery
        • 8.5.8.4. Market Size and Forecast, By End User

      • 8.5.9. Saudi Arabia Medication Management Market

        • 8.5.9.1. Market Size and Forecast, By System
        • 8.5.9.2. Market Size and Forecast, By Service
        • 8.5.9.3. Market Size and Forecast, By Mode Of Delivery
        • 8.5.9.4. Market Size and Forecast, By End User

      • 8.5.10. UAE Medication Management Market

        • 8.5.10.1. Market Size and Forecast, By System
        • 8.5.10.2. Market Size and Forecast, By Service
        • 8.5.10.3. Market Size and Forecast, By Mode Of Delivery
        • 8.5.10.4. Market Size and Forecast, By End User

      • 8.5.11. Argentina Medication Management Market

        • 8.5.11.1. Market Size and Forecast, By System
        • 8.5.11.2. Market Size and Forecast, By Service
        • 8.5.11.3. Market Size and Forecast, By Mode Of Delivery
        • 8.5.11.4. Market Size and Forecast, By End User

      • 8.5.12. Rest of LAMEA Medication Management Market

        • 8.5.12.1. Market Size and Forecast, By System
        • 8.5.12.2. Market Size and Forecast, By Service
        • 8.5.12.3. Market Size and Forecast, By Mode Of Delivery
        • 8.5.12.4. Market Size and Forecast, By End User

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Allscripts Healthcare Solutions, Inc.,

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Carefusion Corporation,

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. GE Healthcare (A Division Of General Electric Company),

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Siemens Healthcare (Subsidiary Of Siemens Ag),

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Mckesson Corporation,

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Cerner Corporation,

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Optum Inc.,

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Quadramed Corporation,

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Omnicell, Inc.

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Meditech

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MEDICATION MANAGEMENT MARKET, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL MEDICATION MANAGEMENT MARKET FOR CLINICAL DECISION SUPPORT SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL MEDICATION MANAGEMENT MARKET FOR COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL MEDICATION MANAGEMENT MARKET FOR ASSURANCE SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL MEDICATION MANAGEMENT MARKET FOR INVENTORY MANAGEMENT SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL MEDICATION MANAGEMENT MARKET FOR ADMINISTRATION SOFTWARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL MEDICATION MANAGEMENT MARKET FOR AUTOMATED DISPENSING SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL MEDICATION MANAGEMENT MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL MEDICATION MANAGEMENT MARKET FOR ADVERSE DRUG EFFECTS SURVEILLANCE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL MEDICATION MANAGEMENT MARKET FOR MEDICATION ANALYTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL MEDICATION MANAGEMENT MARKET FOR POINT-OF-CARE VERIFICATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL MEDICATION MANAGEMENT MARKET, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL MEDICATION MANAGEMENT MARKET FOR WEB-BASED, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL MEDICATION MANAGEMENT MARKET FOR CLOUD-BASED, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL MEDICATION MANAGEMENT MARKET FOR ON-PREMISE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL MEDICATION MANAGEMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL MEDICATION MANAGEMENT MARKET FOR PHARMACIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL MEDICATION MANAGEMENT MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL MEDICATION MANAGEMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL MEDICATION MANAGEMENT MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA MEDICATION MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. U.S. MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 27. U.S. MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 28. U.S. MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 29. U.S. MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. CANADA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 31. CANADA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 32. CANADA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 33. CANADA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 36. MEXICO MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE MEDICATION MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 41. EUROPE MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. FRANCE MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 44. FRANCE MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. GERMANY MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. ITALY MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 52. ITALY MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 53. ITALY MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 54. ITALY MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. SPAIN MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 56. SPAIN MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. UK MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 60. UK MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 61. UK MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 62. UK MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. RUSSIA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 64. RUSSIA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 65. RUSSIA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 66. RUSSIA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. REST OF EUROPE MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 68. REST OF EUROPE MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 69. REST OF EUROPE MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 70. REST OF EUROPE MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. ASIA-PACIFIC MEDICATION MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 72. ASIA-PACIFIC MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 73. ASIA-PACIFIC MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 74. ASIA-PACIFIC MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 75. ASIA-PACIFIC MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. CHINA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 77. CHINA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 78. CHINA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 79. CHINA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. JAPAN MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 81. JAPAN MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 82. JAPAN MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 83. JAPAN MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. INDIA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 85. INDIA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 86. INDIA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 87. INDIA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH KOREA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH KOREA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH KOREA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. AUSTRALIA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 93. AUSTRALIA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 94. AUSTRALIA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 95. AUSTRALIA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. THAILAND MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 97. THAILAND MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 98. THAILAND MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 99. THAILAND MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. MALAYSIA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 101. MALAYSIA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 102. MALAYSIA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 103. MALAYSIA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. INDONESIA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 105. INDONESIA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 106. INDONESIA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 107. INDONESIA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. REST OF ASIA PACIFIC MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 110. REST OF ASIA PACIFIC MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 111. REST OF ASIA PACIFIC MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 112. LAMEA MEDICATION MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 113. LAMEA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 114. LAMEA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 115. LAMEA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 116. LAMEA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 117. BRAZIL MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 118. BRAZIL MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 119. BRAZIL MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 120. BRAZIL MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 121. SOUTH AFRICA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 122. SOUTH AFRICA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 123. SOUTH AFRICA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 124. SOUTH AFRICA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 125. SAUDI ARABIA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 126. SAUDI ARABIA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 127. SAUDI ARABIA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 128. SAUDI ARABIA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 129. UAE MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 130. UAE MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 131. UAE MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 132. UAE MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 133. ARGENTINA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 134. ARGENTINA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 135. ARGENTINA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 136. ARGENTINA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 137. REST OF LAMEA MEDICATION MANAGEMENT, BY SYSTEM, 2022-2032 ($MILLION)
  • TABLE 138. REST OF LAMEA MEDICATION MANAGEMENT, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 139. REST OF LAMEA MEDICATION MANAGEMENT, BY MODE OF DELIVERY, 2022-2032 ($MILLION)
  • TABLE 140. REST OF LAMEA MEDICATION MANAGEMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 141. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.,: KEY EXECUTIVES
  • TABLE 142. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.,: COMPANY SNAPSHOT
  • TABLE 143. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.,: OPERATING SEGMENTS
  • TABLE 144. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.,: PRODUCT PORTFOLIO
  • TABLE 145. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 146. CAREFUSION CORPORATION,: KEY EXECUTIVES
  • TABLE 147. CAREFUSION CORPORATION,: COMPANY SNAPSHOT
  • TABLE 148. CAREFUSION CORPORATION,: OPERATING SEGMENTS
  • TABLE 149. CAREFUSION CORPORATION,: PRODUCT PORTFOLIO
  • TABLE 150. CAREFUSION CORPORATION,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 151. GE HEALTHCARE (A DIVISION OF GENERAL ELECTRIC COMPANY),: KEY EXECUTIVES
  • TABLE 152. GE HEALTHCARE (A DIVISION OF GENERAL ELECTRIC COMPANY),: COMPANY SNAPSHOT
  • TABLE 153. GE HEALTHCARE (A DIVISION OF GENERAL ELECTRIC COMPANY),: OPERATING SEGMENTS
  • TABLE 154. GE HEALTHCARE (A DIVISION OF GENERAL ELECTRIC COMPANY),: PRODUCT PORTFOLIO
  • TABLE 155. GE HEALTHCARE (A DIVISION OF GENERAL ELECTRIC COMPANY),: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 156. SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG),: KEY EXECUTIVES
  • TABLE 157. SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG),: COMPANY SNAPSHOT
  • TABLE 158. SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG),: OPERATING SEGMENTS
  • TABLE 159. SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG),: PRODUCT PORTFOLIO
  • TABLE 160. SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG),: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 161. MCKESSON CORPORATION,: KEY EXECUTIVES
  • TABLE 162. MCKESSON CORPORATION,: COMPANY SNAPSHOT
  • TABLE 163. MCKESSON CORPORATION,: OPERATING SEGMENTS
  • TABLE 164. MCKESSON CORPORATION,: PRODUCT PORTFOLIO
  • TABLE 165. MCKESSON CORPORATION,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 166. CERNER CORPORATION,: KEY EXECUTIVES
  • TABLE 167. CERNER CORPORATION,: COMPANY SNAPSHOT
  • TABLE 168. CERNER CORPORATION,: OPERATING SEGMENTS
  • TABLE 169. CERNER CORPORATION,: PRODUCT PORTFOLIO
  • TABLE 170. CERNER CORPORATION,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 171. OPTUM INC.,: KEY EXECUTIVES
  • TABLE 172. OPTUM INC.,: COMPANY SNAPSHOT
  • TABLE 173. OPTUM INC.,: OPERATING SEGMENTS
  • TABLE 174. OPTUM INC.,: PRODUCT PORTFOLIO
  • TABLE 175. OPTUM INC.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 176. QUADRAMED CORPORATION,: KEY EXECUTIVES
  • TABLE 177. QUADRAMED CORPORATION,: COMPANY SNAPSHOT
  • TABLE 178. QUADRAMED CORPORATION,: OPERATING SEGMENTS
  • TABLE 179. QUADRAMED CORPORATION,: PRODUCT PORTFOLIO
  • TABLE 180. QUADRAMED CORPORATION,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 181. OMNICELL, INC.: KEY EXECUTIVES
  • TABLE 182. OMNICELL, INC.: COMPANY SNAPSHOT
  • TABLE 183. OMNICELL, INC.: OPERATING SEGMENTS
  • TABLE 184. OMNICELL, INC.: PRODUCT PORTFOLIO
  • TABLE 185. OMNICELL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 186. MEDITECH: KEY EXECUTIVES
  • TABLE 187. MEDITECH: COMPANY SNAPSHOT
  • TABLE 188. MEDITECH: OPERATING SEGMENTS
  • TABLE 189. MEDITECH: PRODUCT PORTFOLIO
  • TABLE 190. MEDITECH: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICATION MANAGEMENT MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MEDICATION MANAGEMENT MARKET
  • FIGURE 3. SEGMENTATION MEDICATION MANAGEMENT MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MEDICATION MANAGEMENT MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMEDICATION MANAGEMENT MARKET
  • FIGURE 11. MEDICATION MANAGEMENT MARKET SEGMENTATION, BY BY SYSTEM
  • FIGURE 12. MEDICATION MANAGEMENT MARKET FOR CLINICAL DECISION SUPPORT SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. MEDICATION MANAGEMENT MARKET FOR COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. MEDICATION MANAGEMENT MARKET FOR ASSURANCE SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. MEDICATION MANAGEMENT MARKET FOR INVENTORY MANAGEMENT SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. MEDICATION MANAGEMENT MARKET FOR ADMINISTRATION SOFTWARE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. MEDICATION MANAGEMENT MARKET FOR AUTOMATED DISPENSING SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. MEDICATION MANAGEMENT MARKET SEGMENTATION, BY BY SERVICE
  • FIGURE 19. MEDICATION MANAGEMENT MARKET FOR ADVERSE DRUG EFFECTS SURVEILLANCE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. MEDICATION MANAGEMENT MARKET FOR MEDICATION ANALYTICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. MEDICATION MANAGEMENT MARKET FOR POINT-OF-CARE VERIFICATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. MEDICATION MANAGEMENT MARKET SEGMENTATION, BY BY MODE OF DELIVERY
  • FIGURE 23. MEDICATION MANAGEMENT MARKET FOR WEB-BASED, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. MEDICATION MANAGEMENT MARKET FOR CLOUD-BASED, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. MEDICATION MANAGEMENT MARKET FOR ON-PREMISE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. MEDICATION MANAGEMENT MARKET SEGMENTATION, BY BY END USER
  • FIGURE 27. MEDICATION MANAGEMENT MARKET FOR PHARMACIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. MEDICATION MANAGEMENT MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. MEDICATION MANAGEMENT MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 31. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 32. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 33. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 34. COMPETITIVE DASHBOARD
  • FIGURE 35. COMPETITIVE HEATMAP: MEDICATION MANAGEMENT MARKET
  • FIGURE 36. Top player positioning, 2022
  • FIGURE 37. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. CAREFUSION CORPORATION,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. CAREFUSION CORPORATION,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. CAREFUSION CORPORATION,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. GE HEALTHCARE (A DIVISION OF GENERAL ELECTRIC COMPANY),: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. GE HEALTHCARE (A DIVISION OF GENERAL ELECTRIC COMPANY),: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. GE HEALTHCARE (A DIVISION OF GENERAL ELECTRIC COMPANY),: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG),: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG),: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG),: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. MCKESSON CORPORATION,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. MCKESSON CORPORATION,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. MCKESSON CORPORATION,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. CERNER CORPORATION,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. CERNER CORPORATION,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. CERNER CORPORATION,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. OPTUM INC.,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. OPTUM INC.,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. OPTUM INC.,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 58. QUADRAMED CORPORATION,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. QUADRAMED CORPORATION,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 60. QUADRAMED CORPORATION,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 61. OMNICELL, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 62. OMNICELL, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 63. OMNICELL, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 64. MEDITECH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 65. MEDITECH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 66. MEDITECH: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Medication Management Market

Start reading.
This Report and over 66,804+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers